Showing results (21-30 of 137) with videos related to

Sort By:
Pageof 14
Journal of Cancer|April 12, 2014
Investigating molecular profiles of ovarian cancer: an update on cancer stem cellsFederica Tomao, Anselmo Papa, Martina Strudel, et al.
Oncotarget|April 9, 2016
How do the results of the RADIANT trials impact on the management of NET patients? A systematic review of published studiesSara Pusceddu, Filippo De Braud, Giuseppe Lo Russo, et al.
Tumori|April 16, 2024
Response to lorlatinib rechallenge in a case of ALK-rearranged metastatic NSCLC with a resistance mutation to second generation TKIsRita Leporati, Daniela Miliziano, Teresa Beninato, et al.
Therapeutic Advances in Medical Oncology|March 28, 2017
Everolimus treatment for neuroendocrine tumors: latest results and clinical potentialSara Pusceddu, Elena Verzoni, Natialie Prinzi, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|July 24, 2014
Focus on genetic and epigenetic events of colorectal cancer pathogenesis: implications for molecular diagnosisFederica Zoratto, Luigi Rossi, Monica Verrico, et al.
Expert Review of Anticancer Therapy|February 15, 2013
Breast cancer risk after exposure to fertility drugsGiuseppe Lo Russo, Gian Paolo Spinelli, Silverio Tomao, et al.
Future Oncology (London, England)|December 12, 2025
A phase III placebo-controlled study of eftilagimod alfa plus pembrolizumab and chemotherapy in metastatic non-small cell lung cancerKenneth O'Byrne, Emilio Esteban, Cheen Leng Lee, et al.
World Journal of Surgical Oncology|July 11, 2012
Breast cancer metastatic to the pituitary gland: a case reportGian Paolo Spinelli, Giuseppe Lo Russo, Evelina Miele, et al.
Journal of Cancer Education : the Official Journal of the American Association for Cancer Education|January 20, 2025
The Implementation of Decision Aids During Medical Consultations for Lung Cancer Patients: A Focus Group Within I3LUNG ProjectValeria Sebri, Patrizia Dorangricchia, Dario Monzani, et al.
Tumori|August 29, 2019
Unusual skin toxicity associated with sustained disease response induced by nivolumab in a patient with non-small cell lung cancerGiulia Galli, Claudia Proto, Mara Cossa, et al.
Pageof 14